3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
4
Genitourinary
3
Plasma cell
2
Sarcoma
1
Conditions
Prostatic Neoplasms
2
Multiple Myeloma
2
Breast Neoplasms
2
Patient Compliance
1
Osteolysis
1
Bone Neoplasms
1
Interventions
Dexamethasone
393
Bortezomib
246
Lenalidomide
222
Cyclophosphamide
184
Melphalan
168
Calcium Dobesilate
119
Peripheral Blood Stem Cell Transplantation
94
fludarabine phosphate
89
Thalidomide
82
Filgrastim
74
carfilzomib
70
pomalidomide
68
Granulocyte Colony-Stimulating Factor
63
Busulfan
63
Mycophenolic Acid
61
daratumumab
58
Whole-Body Irradiation
57
ixazomib
54
fludarabine
52
Tacrolimus
52
Prednisone
51
Cyclosporine
50
Antilymphocyte Serum
35
dexamethasone acetate
32
plerixafor
30
Etoposide
30
Methotrexate
29
Radiotherapy
28
dexamethasone 21-phosphate
27
Doxorubicin
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Clodronic Acid
×
Plasma cell
×
Clear all
NCT01198457
2012-09-07
BONA
Bayer
Completed
147 enrolled
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled